Equities researchers at StockNews.com initiated coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Rating) in a report issued on Friday. The firm set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance GNCA opened at $0.00 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.35 […]